Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Revlar Diagnostics logo — Developing breakthrough infectious disease diagnostic soluti...

Revlar Diagnostics

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and simplicity

Founded 2019 United States Los Angeles, United States 4 employees Biotechnology, Health Care

General Information

Company Name Revlar Diagnostics
Founded Year 2019
Location United States Los Angeles, United States
Employees 4
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Revlar Diagnostics. To contact Revlar Diagnostics, visit revlardx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Revlar Diagnostics compare?

A PDF of Revlar Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Revlar Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Revlar Diagnostics

Revlar Diagnostics is a biotechnology and healthcare startup based in the United States, founded in 2019. The company's slogan, "Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity, and simplicity," encapsulates its mission. Revlar Labs aims to revolutionize infectious disease diagnostics in both commercial and laboratory markets. Their approach includes Covid-targeted assays utilizing patented biosensors in vitro, as well as on-site and Point of Care diagnostic solutions. The company's offerings address the challenges associated with typical PCR and rapid antigen tests for COVID. By leveraging hinged peptid molecular nanoswitches, Revlar Labs has designed a better diagnostic solution that promises speed, simplicity, and sensitivity, enabling labs to scale accurate, rapid-results tests. Their CLIA LAB solutions encompass Covid-targeted assay development and High-Throughput Lab (HTL) kits. Additionally, they provide on-site Covid solutions suitable for Point of Care providers, venues, employers, and school campuses. Revlar Diagnostics presents an innovative and timely solution to the pressing need for reliable and efficient infectious disease diagnostics. Their focus on scalability, accuracy, and speed makes them a promising player in the biotechnology and healthcare industries. As of now, there's no publicly available information about their last investment, investors, or investment amount. For potential investors seeking opportunities in the infectious disease diagnostics space, Revlar Diagnostics could be an intriguing prospect. For further information, interested parties can reach out to Tony via [email protected] .

Business keywords: Infectious Disease Diagnostics, Molecular Assays, COVID-19 Diagnostics, Point of Care Solutions, CLIA Lab, Pathology, Biosensors, High-Throughput Lab Kits, SARS-CoV-2, Rapid Diagnostics, Nanoswitches, Venues, Employers, School Campuses

No funding data available for Revlar Diagnostics yet.

Revlar Diagnostics Alternatives & Competitors

View All Alternatives
Revlar Diagnostics vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
Revlar Diagnostics vs
Lucira Health
Lucira Health

Empowering you with rapid, lab-accurate molecular testing in the palm of your hand

Post-IPO Debt
51-200 employees
Biotechnology, Health Care
Revlar Diagnostics vs
NeoDx
NeoDx India

Precision Diagnostics: Reliable Results, Affordable Solutions

33 employees
Biotechnology, Health Care
View all alternatives

FAQ About Revlar Diagnostics

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and simplicity
Revlar Diagnostics was founded in 2019.
Revlar Diagnostics is headquartered in Los Angeles, United States.
Revlar Diagnostics operates in Biotechnology and Health Care. Its work centres on Infectious Disease Diagnostics, Molecular Assays, COVID-19 Diagnostics and Point of Care Solutions.
Revlar Diagnostics has approximately 4 employees.
Top alternatives and competitors to Revlar Diagnostics include G2M | Next Generation IVD solutions for Genomics, Lucira Health, NeoDx , Aldatu Biosciences, FRIZ Biochem GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Revlar Diagnostics and G2M | Next Generation IVD solutions for Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Revlar Diagnostics, https://bouncewatch.com/company/revlar-diagnostics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes